Deciphering an isolated lung phenotype of NKX2-1 frameshift pathogenic variant
暂无分享,去创建一个
S. Simon | R. Epaud | X. Decrouy | A. Aissat | E. Nattes | P. Fanen | C. Delestrain | I. Gibertini | V. Lacroze | A. de Becdelièvre
[1] OUP accepted manuscript , 2022, Nucleic Acids Research.
[2] M. Yaffe,et al. TAZ/WWTR1 Mediates the Pulmonary Effects of NKX2-1 Mutations in Brain-Lung-Thyroid Syndrome , 2018, The Journal of clinical endocrinology and metabolism.
[3] T. Todros,et al. Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature. , 2018, Minerva ginecologica.
[4] R. Epaud,et al. Heterogeneity of lung disease associated with NK2 homeobox 1 mutations. , 2017, Respiratory medicine.
[5] S. Simon,et al. Deciphering the mechanism of Q145H SFTPC mutation unmasks a splicing defect and explains the severity of the phenotype , 2017, European Journal of Human Genetics.
[6] A. Munnich,et al. Mutations in BOREALIN cause thyroid dysgenesis , 2016, Human Molecular Genetics.
[7] Silvio C. E. Tosatto,et al. InterPro in 2017—beyond protein family and domain annotations , 2016, Nucleic Acids Res..
[8] A. Visel,et al. Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons , 2016, Neuron.
[9] J. Seidenberg,et al. Lung disease caused by ABCA3 mutations , 2016, Thorax.
[10] J. Whitsett,et al. Alveolar development and disease. , 2015, American journal of respiratory cell and molecular biology.
[11] L. Persani,et al. Novel NKX2-1 Frameshift Mutations in Patients with Atypical Phenotypes of the Brain-Lung-Thyroid Syndrome , 2014, European Thyroid Journal.
[12] H. Ropers,et al. Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum , 2014, Journal of Medical Genetics.
[13] J. Rosenfeld,et al. Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. , 2013, Chest.
[14] P. Macchia,et al. Identification and functional characterization of a novel mutation in the NKX2-1 gene: comparison with the data in the literature. , 2013, Thyroid : official journal of the American Thyroid Association.
[15] Alan Bridge,et al. New and continuing developments at PROSITE , 2012, Nucleic Acids Res..
[16] A. Jobe,et al. Physiology of transition from intrauterine to extrauterine life. , 2012, Clinics in perinatology.
[17] M. Vidailhet,et al. Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[18] D. Mu,et al. Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2–1)* , 2012, The Journal of Biological Chemistry.
[19] L. Guillot,et al. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. , 2012, Human molecular genetics.
[20] T. Volkert,et al. Genome-Wide Analyses of Nkx2-1 Binding to Transcriptional Target Genes Uncover Novel Regulatory Patterns Conserved in Lung Development and Tumors , 2012, PloS one.
[21] J. Rello,et al. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study , 2011, Critical care.
[22] R. Epaud,et al. Interstitial lung diseases in children , 2010, Orphanet journal of rare diseases.
[23] DelindaA . Johnson,et al. Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein , 2009, Journal of neurochemistry.
[24] M. Tomita,et al. Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs , 2009, Proceedings of the National Academy of Sciences.
[25] M. Polak,et al. Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. , 2009, Human molecular genetics.
[26] J. Whitsett,et al. Genetic Disorders of Surfactant Dysfunction , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[27] J. Parma,et al. Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the TITF1/NKX2.1 gene. , 2009, The Journal of clinical endocrinology and metabolism.
[28] J. Pérez-Gil,et al. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. , 2008, Biochimica et biophysica acta.
[29] J. Whitsett,et al. STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells. , 2008, American journal of respiratory cell and molecular biology.
[30] S. Anderson,et al. NKX2.1 specifies cortical interneuron fate by activating Lhx6 , 2008, Development.
[31] V. Giguère,et al. Estrogen related receptor-α enhances Surfactant Protein-A gene expression in fetal lung type II cells , 2006 .
[32] J. Wiener-Kronish,et al. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. , 2006, American journal of respiratory cell and molecular biology.
[33] M. Abramowicz,et al. Thyroid transcription factor 1 rescues PAX8/p300 synergism impaired by a natural PAX8 paired domain mutation with dominant negative activity. , 2005, Molecular endocrinology.
[34] M. Polak,et al. PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. , 2005, The Journal of clinical endocrinology and metabolism.
[35] M. Yaffe,et al. TAZ Interacts with TTF-1 and Regulates Expression of Surfactant Protein-C* , 2004, Journal of Biological Chemistry.
[36] M. Zannini,et al. The Paired Domain-containing Factor Pax8 and the Homeodomain-containing Factor TTF-1 Directly Interact and Synergistically Activate Transcription* , 2003, The Journal of Biological Chemistry.
[37] G. Tell,et al. Redox Effector Factor-1 Regulates the Activity of Thyroid Transcription Factor 1 by Controlling the Redox State of the N Transcriptional Activation Domain* , 2002, The Journal of Biological Chemistry.
[38] R. Weiss,et al. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. , 2002, The Journal of clinical investigation.
[39] Matthias Mann,et al. Paraspeckles A Novel Nuclear Domain , 2002, Current Biology.
[40] F. Askin,et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. , 2001, The New England journal of medicine.
[41] J. Parma,et al. Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. , 2001, The Journal of clinical endocrinology and metabolism.
[42] R. Lauro,et al. Pax8 has a key role in thyroid cell differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. Zammarchi,et al. Role for p300 in Pax 8 Induction of Thyroperoxidase Gene Expression* , 2000, The Journal of Biological Chemistry.
[44] P. Minoo,et al. Two functionally distinct forms of NKX2.1 protein are expressed in the pulmonary epithelium. , 2000, Biochemical and biophysical research communications.
[45] J. Whitsett,et al. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. , 2000, American journal of respiratory and critical care medicine.
[46] Ahmed Mansouri,et al. Follicular cells of the thyroid gland require Pax8 gene function , 1998, Nature Genetics.
[47] S. Kimura,et al. Multiple transcripts encoded by the thyroid-specific enhancer-binding protein (T/EBP)/thyroid-specific transcription factor-1 (TTF-1) gene: evidence of autoregulation. , 1998, Endocrinology.
[48] C. Jones,et al. Structure of the human Nkx2.1 gene. , 1998, Biochimica et biophysica acta.
[49] S. Ghaffari,et al. Diverse effects of anti‐CD44 antibodies on the stromal cell‐mediated support of normal but not leukaemic (CML) haemopoiesis in vitro , 1997, British journal of haematology.
[50] S. E. Kelly,et al. Transcription of the Lung-specific Surfactant Protein C Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1996, The Journal of Biological Chemistry.
[51] M. Arnone,et al. Mapping and Functional Role of Phosphorylation Sites in the Thyroid Transcription Factor-1 (TTF-1) (*) , 1996, The Journal of Biological Chemistry.
[52] C H Fox,et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.
[53] J. Whitsett,et al. Upstream Enhancer Activity in the Human Surfactant Protein B Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1995, The Journal of Biological Chemistry.
[54] M. Arnone,et al. The DNA Binding Activity and the Dimerization Ability of the Thyroid Transcription Factor I Are Redox Regulated (*) , 1995, The Journal of Biological Chemistry.
[55] H. Colten,et al. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. , 1993, The New England journal of medicine.
[56] R. Lauro,et al. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters , 1992, Molecular and cellular biology.
[57] F. Gonzalez,et al. thyroid transcription factor TTF-1 . characterization , and structural identity with ( T / EBP ) : cDNA cloning , functional Thyroid-specific enhancer-binding protein , 1991 .
[58] R. Lauro,et al. A thyroid‐specific nuclear protein essential for tissue‐specific expression of the thyroglobulin promoter. , 1989, The EMBO journal.